Monte Rosa Therapeutics, Inc. - COM (GLUE)

Historical Portfolio Holders from Q2 2021 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
45.8M
Holdings value Q2 2024
$171M
Value change Q2 2024
+$22M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
73
Number of buys Q2 2024
4
Number of sells Q2 2024
-3
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 253K $1.32M -$290K $5.30 9
2024 Q2 45.8M $171M +$22M $3.74 74
2024 Q1 39.9M $281M -$732K $7.05 68
2023 Q4 40.1M $227M -$10M $5.65 72
2023 Q3 42M $201M +$10.9M $4.79 72
2023 Q2 39.7M $272M -$3.2M $6.85 68
2023 Q1 39.8M $310M -$11.1M $7.79 69
2022 Q4 41.2M $314M +$7.27M $7.61 66
2022 Q3 40.3M $329M -$3.97M $8.17 69
2022 Q2 38.8M $375M -$11.9M $9.67 56
2022 Q1 39.9M $560M +$42M $14.02 52
2021 Q4 36.3M $742M +$28.1M $20.42 53
2021 Q3 34.9M $759M +$60.7M $22.28 54
2021 Q2 32.1M $705M +$705M $22.70 48